Skip to main content
Mega Genomics Limited logo

Mega Genomics Limited — Investor Relations & Filings

Ticker · 6667 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 317 across all filing types
Latest filing 2024-12-20 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 6667

About Mega Genomics Limited

https://www.megagenomics.cn

Mega Genomics Limited operates as a genetic testing platform company focused on providing consumer genetic testing and cancer screening services. The core business involves delivering comprehensive genetic analysis solutions to the consumer market. Key product offerings include advanced sequencing packages such as Personal Whole Genome Sequencing, which analyzes over 700,000 genetic loci to assess disease risk and provide pharmacogenomic recommendations. Additionally, the company offers Adult and Children's Whole Exome Sequencing packages, which analyze over 180,000 key exome regions to evaluate risks for high-risk diseases, hereditary cancers, and complex genetic disorders, alongside personalized guidance on drug efficacy, nutrition, and fitness.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns
Transaction in Own Shares Classification · 1% confidence The document is a Hong Kong Stock Exchange Next Day Disclosure Return (Form FF305) detailing changes in issued shares, treasury share redemptions, and a repurchase report under Main Board/GEM Rules, including daily share repurchase transactions. This is a statutory disclosure of the company’s buyback of its own shares, fitting the definition of Transaction in Own Shares.
2024-12-20 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 1% confidence The document is a Hong Kong Stock Exchange FF305 Next Day Disclosure Return detailing changes in issued shares, treasury shares, and a comprehensive report on share repurchases (including dates, volumes, and prices). This type of filing is a report of the company buying back its own shares. Under the provided definitions, this corresponds to “Transaction in Own Shares” (Code: POS).
2024-12-19 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 1% confidence The document is an HKEX "Next Day Disclosure Return" (Form FF305) detailing changes in issued shares and treasury shares, specifically extensive tables of shares repurchased on-market for cancellation and held as treasury shares, and a repurchase report in Section II. This is a mandatory disclosure of the company's own share transactions (buybacks), which corresponds to our "Transaction in Own Shares" category.
2024-12-18 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 1% confidence The document is a detailed Next Day Disclosure Return filed under Hong Kong Listing Rules, specifically reporting changes in issued shares and treasury shares and detailed on­market share repurchase transactions (prices, dates, quantities) by the issuer. This is not an annual or quarterly report, earnings release, proxy statement, or board change notice, but a regulatory submission detailing the company’s own share transactions. Therefore it best fits the “Transaction in Own Shares” category (Code: POS).
2024-12-17 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 1% confidence The document is a Next Day Disclosure Return (FF305) filed under Hong Kong Main Board/GEM rules, detailing changes in issued shares, share repurchases and on‐market sales of treasury shares. It includes Section I reporting issued/treasury share movements and Section II as a repurchase report with trading dates, numbers of shares repurchased, prices, and confirmations under listing rules. This is a report on the company buying back its own shares, matching the “Transaction in Own Shares” category.
2024-12-16 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 1% confidence The document is a Hong Kong Exchange "Next Day Disclosure Return" (Form FF305) detailing changes in issued shares, treasury shares, and extensive repurchase transactions (on-market share buybacks). This directly matches the definition of a Transaction in Own Shares report (company buying back or selling its own shares). It is not an announcement of a report and is the actual disclosure itself.
2024-12-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.